Gilead Sciences Inc. (GILD)
NASDAQ · Healthcare
Gilead Sciences Inc. Operating Income 2007–2025
Gilead Sciences Inc. annual/quarterly operating income history and growth rate from 2007 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Gilead Sciences Inc. operating income for the quarter ending March 31, 2026 was 2.6 B, a 15.60% increase year-over-year.
- Gilead Sciences Inc. operating income for the twelve months ending March 31, 2026 was 10.6 B, a 479.60% increase year-over-year.
- Gilead Sciences Inc. annual operating income for 2025 was 10.0 B, a 503.01% increase from 2024.
- Gilead Sciences Inc. annual operating income for 2024 was 1.7 B, a 78.15% decrease from 2023.
- Gilead Sciences Inc. annual operating income for 2023 was 7.6 B, a 3.75% increase from 2022.
- Gilead Sciences Inc. annual operating income for 2022 was 7.3 B.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Gilead Sciences Inc. Operating Income — FAQ
Gilead Sciences Inc. (GILD) operating income over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
What is Gilead Sciences Inc.'s operating income?
Gilead Sciences Inc. (GILD) reported operating income of $10.02B for fiscal 2025.
Where can I see GILD's operating income history?
The chart and table above show Gilead Sciences Inc.'s operating income by year and by quarter, including the growth rate.